BRIDION

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug BRIDION contains one active pharmaceutical ingredient (API):

1	Sugammadex UNII ERJ6X2MXV7 - SUGAMMADEX SODIUM
	Sugammadex is a modified gamma cyclodextrin which is a Selective Relaxant Binding Agent. It forms a complex with the neuromuscular blocking agents rocuronium or vecuronium in plasma and thereby reduces the amount of neuromuscular blocking agent available to bind to nicotinic receptors in the neuromuscular junction.
	Read more about Sugammadex

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BRIDION Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AB35	Sugammadex	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB35

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	537701002159212
CA	Health Products and Food Branch	02451816
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	4340-MEE-0818
EE	Ravimiamet	1364701, 1364712
ES	Centro de información online de medicamentos de la AEMPS	08466001, 08466002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	140130, 140141
FR	Base de données publique des médicaments	64333487
GB	Medicines & Healthcare Products Regulatory Agency	147463, 147466
HK	Department of Health Drug Office	66405
IL	מִשְׂרַד הַבְּרִיאוּת	6583
JP	医薬品医療機器総合機構	3929409A1023, 3929409A2020
LT	Valstybinė vaistų kontrolės tarnyba	1033699, 1033700
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	176M2011
NL	Z-Index G-Standaard, PRK	87297, 87300
NZ	Medicines and Medical Devices Safety Authority	13352
PL	Rejestru Produktów Leczniczych	100197198
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64745001, W64745002
SG	Health Sciences Authority	13812P
TN	Direction de la Pharmacie et du Médicament	3443131H, 6023131H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699636771020
US	FDA, National Drug Code	0006-5423, 0006-5425, 71872-7187
ZA	Health Products Regulatory Authority	44/34/0432